Full View

Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: patient perspectives from the ECLAIR trial

MI Murray, M Markowitz, I Frank, RM Grant… - HIV clinical …, 2018 - Taylor & Francis
Background: Cabotegravir (GSK1265744) is an integrase strand transfer inhibitor in
development as a long-acting (LA) intramuscular injectable suspension for HIV-1 pre …
被引用次数：63 相关文章

Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial.

MI Murray, M Markowitz, I Frank, RM Grant… - HIV Clinical …, 2018 - europepmc.org
Background Cabotegravir (GSK1265744) is an integrase strand transfer inhibitor in
development as a long-acting (LA) intramuscular injectable suspension for HIV-1 pre …

Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial

MI Murray, M Markowitz, I Frank, RM Grant, KH Mayer… - 2018 - pubmed.ncbi.nlm.nih.gov
Background Cabotegravir (GSK1265744) is an integrase strand transfer inhibitor in
development as a long-acting (LA) intramuscular injectable suspension for HIV-1 pre …